In this episode Mike Ward, head of the firm’s Life Sciences group, discusses how the availability of the COVID-19 vaccine may impact the workforce, including compliance requirements, employer/employee rights, with Janie Schulman, employment and labor partner and key member of the firm’s COVID-19 task force.
In this episode Mike Ward, head of the firm’s Life Sciences group, discusses the path toward a therapy for COVID-19 focusing on the science with Janet Xiao, and on legal considerations including regulatory with Bethany Hills; and commercial transactions with Rufus Pichler.
In this episode Mike Ward, head of the firm’s Life Sciences group, discusses the path toward a vaccine for COVID-19 focusing on the science with Otis Littlefield, and on legal considerations including regulatory with Bethany Hills; and commercial transactions with Rufus Pichler.
In this episode Mike Ward, head of the firm’s Life Sciences group, discusses applying AI and data science to the fight against COVID-19 focusing on the science with Jean Nguyen, and on legal considerations including privacy and data security with Kristen Mathews; regulatory with Bethany Hills; and commercial transactions with Matt Karlyn.
In this episode Mike Ward, head of the firm’s Life Sciences group, discusses the unique aspects of the health crisis on the science, with Jim Mullen; the regulatory framework, with Bethany Hills; the commercial transactions, with Matt Karlyn; and the privacy and data security considerations with Kristen Mathews.
Disclaimer
Unsolicited e-mails and information sent to Morrison & Foerster will not be considered confidential, may be disclosed to others pursuant to our Privacy Policy, may not receive a response, and do not create an attorney-client relationship with Morrison & Foerster. If you are not already a client of Morrison & Foerster, do not include any confidential information in this message. Also, please note that our attorneys do not seek to practice law in any jurisdiction in which they are not properly authorized to do so.
